Lupin

Global pharma major Lupin announced its strategic collaboration with LABORATORIOS ERN S.A. (ERN), a well‑established Spanish…

ANDA approval covers Eribulin Mesylate Injection, the bioequivalent of Halaven Injection, for metastatic breast cancer and…

Approval grants Lupin 180-day generic drug exclusivity for Sodium Sulfate, Magnesium Sulfate, and Potassium Chloride Tablets in…

Global pharma major Lupin announced that it has received the Establishment Inspection Report (EIR) from the United States Food and…

Global pharma major Lupin announced that China’s National Medical Products Administration has approved its Abbreviated New Drug…

Global pharma major, Lupin announced that it has received tentative approval from the United States Food and Drug Administration…

Global pharma major Lupin announced the launch of Atharv Ability, its world-class neuro-rehabilitation center in Naraina Vihar,…

This product would be manufactured at Lupin’s Nagpur facility in India

Global pharma major Lupin announced that it has received approval from the United States Food and Drug Administration for its…

Global pharma major Lupin Limited (Lupin) today announced that it has received approval from the United States Food and Drug…